Lonza Group Ltd (LZAGY)
58.09
+0.17
(+0.29%)
USD |
OTCM |
May 17, 16:00
Lonza Group Total Long Term Debt (Quarterly): 3.335B for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 3.335B |
June 30, 2023 | 3.236B |
December 31, 2022 | 2.407B |
June 30, 2022 | 2.518B |
December 31, 2021 | 2.629B |
June 30, 2021 | 3.960B |
December 31, 2020 | 4.098B |
June 30, 2020 | 4.012B |
December 31, 2019 | 3.654B |
June 30, 2019 | 3.874B |
December 31, 2018 | 4.115B |
June 30, 2018 | 4.229B |
December 31, 2017 | 4.347B |
June 30, 2017 | 1.796B |
December 31, 2016 | 1.828B |
June 30, 2016 | 1.799B |
Date | Value |
---|---|
December 31, 2015 | 1.956B |
June 30, 2015 | 2.232B |
December 31, 2014 | 2.241B |
June 30, 2014 | 2.760B |
December 31, 2013 | 2.791B |
June 30, 2013 | 2.952B |
December 31, 2012 | 3.084B |
June 30, 2012 | 2.992B |
December 31, 2011 | 3.084B |
June 30, 2011 | 1.674B |
December 31, 2010 | 1.562B |
June 30, 2010 | 1.311B |
December 31, 2009 | 1.443B |
June 30, 2009 | 0.00 |
December 31, 2008 | 2.183B |
June 30, 2008 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
2.407B
Minimum
Dec 2022
4.098B
Maximum
Dec 2020
3.372B
Average
3.494B
Median
Total Long Term Debt (Quarterly) Benchmarks
Roche Holding AG | 34.77B |
AC Immune SA | -- |
CRISPR Therapeutics AG | -- |
Addex Therapeutics Ltd | 0.00 |
NLS Pharmaceutics Ltd | -- |